The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials
-
Published:2017-04
Issue:
Volume:75
Page:245-258
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Roviello GiandomenicoORCID,
Bachelot Thomas,
Hudis Clifford A.,
Curigliano Giuseppe,
Reynolds Andrew R.,
Petrioli Roberto,
Generali Daniele
Subject
Cancer Research,Oncology
Reference60 articles.
1. The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer. Where does it fit?;Eskens;Eur J Cancer,2008
2. Targeting signal transduction pathways in metastatic breast cancer a comprehensive review;Rosen;Oncologist,2010
3. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment;Linderholm;J Clin Oncol,2000
4. Tumor angiogenesis;Kerbel;N Engl J Med,2008
5. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity;Alon;Nat Med,1995
Cited by
84 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献